260 related articles for article (PubMed ID: 20231670)
1. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Zesiewicz TA; Sullivan KL; Arnulf I; Chaudhuri KR; Morgan JC; Gronseth GS; Miyasaki J; Iverson DJ; Weiner WJ;
Neurology; 2010 Mar; 74(11):924-31. PubMed ID: 20231670
[TBL] [Abstract][Full Text] [Related]
2. The impact and management of nonmotor symptoms of Parkinson's disease.
Lyons KE; Pahwa R
Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
[TBL] [Abstract][Full Text] [Related]
3. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Miyasaki JM; Shannon K; Voon V; Ravina B; Kleiner-Fisman G; Anderson K; Shulman LM; Gronseth G; Weiner WJ;
Neurology; 2006 Apr; 66(7):996-1002. PubMed ID: 16606910
[TBL] [Abstract][Full Text] [Related]
4. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Suchowersky O; Gronseth G; Perlmutter J; Reich S; Zesiewicz T; Weiner WJ;
Neurology; 2006 Apr; 66(7):976-82. PubMed ID: 16606908
[TBL] [Abstract][Full Text] [Related]
5. Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Suchowersky O; Reich S; Perlmutter J; Zesiewicz T; Gronseth G; Weiner WJ;
Neurology; 2006 Apr; 66(7):968-75. PubMed ID: 16606907
[TBL] [Abstract][Full Text] [Related]
6. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
Seppi K; Weintraub D; Coelho M; Perez-Lloret S; Fox SH; Katzenschlager R; Hametner EM; Poewe W; Rascol O; Goetz CG; Sampaio C
Mov Disord; 2011 Oct; 26 Suppl 3(0 3):S42-80. PubMed ID: 22021174
[TBL] [Abstract][Full Text] [Related]
7. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Zesiewicz TA; Elble R; Louis ED; Hauser RA; Sullivan KL; Dewey RB; Ondo WG; Gronseth GS; Weiner WJ;
Neurology; 2005 Jun; 64(12):2008-20. PubMed ID: 15972843
[TBL] [Abstract][Full Text] [Related]
8. Nonmotor manifestations of Parkinson's disease.
Simuni T; Sethi K
Ann Neurol; 2008 Dec; 64 Suppl 2():S65-80. PubMed ID: 19127582
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for autonomic dysfunction in Parkinson's disease.
Perez-Lloret S; Rey MV; Pavy-Le Traon A; Rascol O
Expert Opin Emerg Drugs; 2013 Mar; 18(1):39-53. PubMed ID: 23373820
[TBL] [Abstract][Full Text] [Related]
10. Non-motor extranigral signs and symptoms in Parkinson's disease.
Wolters ECh
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
[TBL] [Abstract][Full Text] [Related]
11. Nonmotor symptoms in Parkinson's disease.
Stacy M
Int J Neurosci; 2011; 121 Suppl 2():9-17. PubMed ID: 22035025
[TBL] [Abstract][Full Text] [Related]
12. Nonmotor symptoms of Parkinson's disease.
Zesiewicz TA; Sullivan KL; Hauser RA
Expert Rev Neurother; 2006 Dec; 6(12):1811-22. PubMed ID: 17181428
[TBL] [Abstract][Full Text] [Related]
13. Practice parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Thurman DJ; Stevens JA; Rao JK;
Neurology; 2008 Feb; 70(6):473-9. PubMed ID: 18250292
[TBL] [Abstract][Full Text] [Related]
14. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
[TBL] [Abstract][Full Text] [Related]
15. [Autonomic disorders in Parkinson's disease].
Gołab-Janowska M; Budzianowska A; Honczarenko K
Ann Acad Med Stetin; 2011; 57(1):11-5; discussion 16. PubMed ID: 22593985
[TBL] [Abstract][Full Text] [Related]
16. Practice parameter: the evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.
England JD; Gronseth GS; Franklin G; Carter GT; Kinsella LJ; Cohen JA; Asbury AK; Szigeti K; Lupski JR; Latov N; Lewis RA; Low PA; Fisher MA; Herrmann D; Howard JF; Lauria G; Miller RG; Polydefkis M; Sumner AJ; ; ;
PM R; 2009 Jan; 1(1):14-22. PubMed ID: 19627868
[TBL] [Abstract][Full Text] [Related]
17. Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.
Wood LD; Neumiller JJ; Setter SM; Dobbins EK
Am J Geriatr Pharmacother; 2010 Aug; 8(4):294-315. PubMed ID: 20869620
[TBL] [Abstract][Full Text] [Related]
18. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.
Snyder CH; Adler CH
J Am Acad Nurse Pract; 2007 Apr; 19(4):179-97. PubMed ID: 17430539
[TBL] [Abstract][Full Text] [Related]
19. Nonmotor symptoms in genetic Parkinson disease.
Kasten M; Kertelge L; Brüggemann N; van der Vegt J; Schmidt A; Tadic V; Buhmann C; Steinlechner S; Behrens MI; Ramirez A; Binkofski F; Siebner H; Raspe H; Hagenah J; Lencer R; Klein C
Arch Neurol; 2010 Jun; 67(6):670-6. PubMed ID: 20558386
[TBL] [Abstract][Full Text] [Related]
20. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
Gallagher DA; Lees AJ; Schrag A
Mov Disord; 2010 Nov; 25(15):2493-500. PubMed ID: 20922807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
